jlightner 
Austin, TX – June 10, 2025 – Tekton Research continues its strategic growth in 2025 with the addition of its fourth new research site this year. The latest partnership is with Richmond Pediatric Associates, a respected multi-physician clinic in Virginia known for delivering comprehensive care across pediatric and adolescent populations. The site brings added pediatric … Read more
Objective Tekton’s Wichita, KS site with lead PI Dr. Brandon Alleman was selected to support a recent clinical trial evaluating a continuous glucose monitoring (CGM) device in pregnant women with diabetes. Pregnancy introduces unique challenges in managing glucose levels, making CGM a vital tool for optimizing maternal and fetal health. Challenge The study presented unique … Read more
Overview Tekton Research delivered exceptional results in a recent Type 1 Diabetes clinical trial by leveraging its multi-site endocrinology expertise, operational efficiency, and proven site management processes. All three Tekton sites exceeded enrollment targets, contributing to the study’s success. Key Metrics 172% Average enrollment across 3 sitesGoal: 18 | Enrolled: >30 1 days Average regulatory … Read more
Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The study required a population of generally healthy adults and demanded rapid site activation and participant enrollment to meet aggressive study timelines. Challenge Norovirus, a highly contagious virus causing gastrointestinal illness, presents significant global public health challenges. … Read more
Objective Tekton was selected to deliver research sites and participants for a Global Phase 3 vaccine clinical trial. The trial required a patient population of generally healthy adults aged ≥50, stratified into three age groups. Challenge Vaccine season brings a surge of clinical research activity—especially for flu-related studies. At the time of this trial, several … Read more
Saint Louis, MO – Tekton Research is proud to announce its partnership with Dr. Ernest A. Graypel, a highly regarded psychiatrist and researcher, Board Certified in Psychiatry and Neurology. This effort supports Tekton’s expanding capabilities in central nervous system (CNS) research, particularly in Behavioral Health sciences. As the Medical Director of Community and Long-Term Care … Read more
As we step into 2025, Tekton Research is proud to reflect on a year filled with growth, innovation, and impactful contributions to clinical research. Tekton extends their gratitude to everyone who played a role in advancing their mission. From the dedicated staff and PI’s, to CRO and biopharma partners, and patients, who generously participated in … Read more
Marlboro, NJ – Tekton Research is pleased to announce that Amor R. Mehta, MD, a leading neurologist specializing in epilepsy, seizure disorders and neurodegenerative diseases, has joined the organization’s collaborative network. With a strong commitment to advancing epilepsy care and epilepsy-related neurodiagnostics in New Jersey, Dr. Mehta brings an unparalleled dedication to enhancing patient outcomes … Read more
Longmont, CO – Tekton Research, a prominent leader in clinical trials with a nationwide network of research facilities established in 2006, is excited to announce its recent partnership with Dr. Alex Reish. An esteemed osteopath specializing in migraines and chronic pain, Dr. Reish joins Tekton Research with a strong passion for innovative care and extensive … Read more
As flu season approaches, Tekton Research is conducting vital studies to enhance vaccine development and is seeking volunteers aged 50 and older to participate. These trials are essential for developing improved protections against the flu, which claims thousands of lives each year. Why This Research Matters “Flu kills thousands of people of all ages every … Read more